<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND DESIGN: This case-control study was undertaken to determine whether anticardiolipin antibodies (ACA) are responsible for particular abnormalities in nailfold capillary microscopy (NCM) </plain></SENT>
<SENT sid="1" pm="."><plain>Cases comprised 33 consecutive patients positive for ACA (24 women and 7 men) </plain></SENT>
<SENT sid="2" pm="."><plain>Controls comprised the same number of ACA-negative patients, with the same sex ratio, the same diagnosis and the most similar duration of disease possible </plain></SENT>
<SENT sid="3" pm="."><plain>Clinical data, serum samples and NCM recordings were obtained from <z:hpo ids='HP_0000001'>all</z:hpo> patients and controls </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: In each group, 22 patients had connective-tissue-related disorders and 11 various other diseases </plain></SENT>
<SENT sid="5" pm="."><plain>In ACA-positive patients, the mean IgG ACA titre was 39 +/- 58 IgG <z:chebi fb="0" ids="16247">phospholipid</z:chebi> units </plain></SENT>
<SENT sid="6" pm="."><plain>Cases and controls displayed various cutaneous manifestations </plain></SENT>
<SENT sid="7" pm="."><plain>In ACA-positive patients, there were <z:e sem="disease" ids="C0034735" disease_type="Disease or Syndrome" abbrv="">Raynaud's phenomenon</z:e> (54%), cutaneous <z:hpo ids='HP_0002633'>vasculitis</z:hpo> (24%), <z:hpo ids='HP_0100324'>scleroderma</z:hpo> changes (18%), <z:hpo ids='HP_0000992'>photosensitivity</z:hpo> (9%), a history of digital <z:hpo ids='HP_0100758'>gangrene</z:hpo> (6%), malar <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rash</z:e> (6%), <z:hpo ids='HP_0001063'>acrocyanosis</z:hpo> (6%), chilblains (3%), <z:hpo ids='HP_0000965'>livedo reticularis</z:hpo> (3%) and <z:hpo ids='HP_0000979'>purpura</z:hpo> (3%) </plain></SENT>
<SENT sid="8" pm="."><plain>Cases and controls exhibited numerous NCM abnormalities </plain></SENT>
<SENT sid="9" pm="."><plain>In ACA-positive patients, they included haemorrhages (54%), <z:hpo ids='HP_0000969'>oedema</z:hpo> (24%), bushy capillaries (21%), disordered capillaries (18%), capillary bed disorganization (12%), capillary rarefaction (9%), giant capillaries (6%) and 'desert areas' (3%) </plain></SENT>
<SENT sid="10" pm="."><plain>There were no correlations between the ACA titres on the one hand and the number of cutaneous manifestations or NCM abnormalities on the other </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: ACA-positive patients frequently exhibit clinical <z:mp ids='MP_0001212'>skin lesions</z:mp> and abnormal NCM </plain></SENT>
<SENT sid="12" pm="."><plain>In this study, these lesions and NCM abnormalities resembled those of the matched ACA-negative controls </plain></SENT>
</text></document>